Patents by Inventor Petra Mooij

Petra Mooij has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8871219
    Abstract: Recombinant vectors which are based on the Modified Ankara Virus (MVA) as preventive and therapeutic vaccines against AIDS. The recombinant viruses contain sequences which are inserted at an MVA insertion site and enable simultaneous expression of antigens, a HIV-1 Env protein consisting of a gp120 protein lacking sequences corresponding to protein gp 41 and a chimeric fusion protein of Gag, Pol and Nef. These viruses are stable and can trigger immune responses against a large variety of antigens. Viruses having a chimeric protein from HIV-1 are suitable for the preparation of vaccines against AIDS.
    Type: Grant
    Filed: July 25, 2006
    Date of Patent: October 28, 2014
    Assignee: Consejo Superior de Investigaciones Cientificas
    Inventors: Jonathan Heeney, Petra Mooij, Carmen Elena Gomez Rodriguez, Jose Luis Najera Garcia, Victoria Jimenez Tentor, Mariano Esteban Rodriguez
  • Publication number: 20100047276
    Abstract: Recombinant vectors which are based on the Modified Ankara Virus (MVA) as preventive and therapeutic vaccines against AIDS. The recombinant viruses object of the invention contain sequences which are inserted at the same MVA insertion site and which enable the simultaneous expression of various antigens, a HIV-1 Env protein consisting of a gp120 protein lacking sequences corresponding to protein gp 41 and a chimeric fusion protein of Gag, Pol and Nef. Said viruses are stable and can trigger immune responses against a large variety of antigens.
    Type: Application
    Filed: July 25, 2006
    Publication date: February 25, 2010
    Inventors: Jonathan Heeney, Petra Mooij, Carmen Elena Gomez Rodriguez, Jose Luis Najera Garcia, Victoria Jimenez Tentor, Mariano Esteban Rodriguez